416 related articles for article (PubMed ID: 22904197)
1. Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
Hacha J; Tomlinson K; Maertens L; Paulissen G; Rocks N; Foidart JM; Noel A; Palframan R; Gueders M; Cataldo DD
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):709-17. PubMed ID: 22904197
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.
Bao ZS; Hong L; Guan Y; Dong XW; Zheng HS; Tan GL; Xie QM
Int Immunopharmacol; 2011 Aug; 11(8):899-906. PubMed ID: 21354484
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling.
Yang G; Volk A; Petley T; Emmell E; Giles-Komar J; Shang X; Li J; Das AM; Shealy D; Griswold DE; Li L
Cytokine; 2004 Dec; 28(6):224-32. PubMed ID: 15566951
[TBL] [Abstract][Full Text] [Related]
4. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Kim SH; Hong JH; Lee YC
Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
[TBL] [Abstract][Full Text] [Related]
5. A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma.
Gueders MM; Bertholet P; Perin F; Rocks N; Maree R; Botta V; Louis R; Foidart JM; Noel A; Evrard B; Cataldo DD
Biochem Pharmacol; 2008 Jan; 75(2):514-26. PubMed ID: 17950252
[TBL] [Abstract][Full Text] [Related]
6. Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma.
Serra MF; Anjos-Valotta EA; Olsen PC; Couto GC; Jurgilas PB; Cotias AC; Pão CR; Ferreira TP; Arantes AC; Pires AL; Cordeiro RS; Silva PM; Martins MA
Anesthesiology; 2012 Sep; 117(3):580-91. PubMed ID: 22846675
[TBL] [Abstract][Full Text] [Related]
7. Geniposide inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma.
Deng Y; Guan M; Xie X; Yang X; Xiang H; Li H; Zou L; Wei J; Wang D; Deng X
Int Immunopharmacol; 2013 Nov; 17(3):561-7. PubMed ID: 23859870
[TBL] [Abstract][Full Text] [Related]
8. Sustained suppression of IL-13 by a vaccine attenuates airway inflammation and remodeling in mice.
Ma Y; Halayko AJ; Basu S; Guan Q; Weiss CR; Ma AG; HayGlass KT; Becker AB; Warrington RJ; Peng Z
Am J Respir Cell Mol Biol; 2013 May; 48(5):540-9. PubMed ID: 23470628
[TBL] [Abstract][Full Text] [Related]
9. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
Ram A; Mabalirajan U; Singh SK; Singh VP; Ghosh B
Int Immunopharmacol; 2008 Jun; 8(6):893-9. PubMed ID: 18442795
[TBL] [Abstract][Full Text] [Related]
10. Protocatechuic acid suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.
Wei M; Chu X; Guan M; Yang X; Xie X; Liu F; Chen C; Deng X
Int Immunopharmacol; 2013 Apr; 15(4):780-8. PubMed ID: 23357785
[TBL] [Abstract][Full Text] [Related]
11. Establishing the phenotype in novel acute and chronic murine models of allergic asthma.
Fernandez-Rodriguez S; Ford WR; Broadley KJ; Kidd EJ
Int Immunopharmacol; 2008 May; 8(5):756-63. PubMed ID: 18387519
[TBL] [Abstract][Full Text] [Related]
12. Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation.
Patil HP; Freches D; Karmani L; Duncan GA; Ucakar B; Suk JS; Hanes J; Gallez B; Vanbever R
J Control Release; 2018 Feb; 272():62-71. PubMed ID: 29247664
[TBL] [Abstract][Full Text] [Related]
13. Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5-HT receptor antagonists in a mouse model of allergic asthma.
De Bie JJ; Henricks PA; Cruikshank WW; Hofman G; Jonker EH; Nijkamp FP; Van Oosterhout AJ
Br J Pharmacol; 1998 Jul; 124(5):857-64. PubMed ID: 9692769
[TBL] [Abstract][Full Text] [Related]
14. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
[TBL] [Abstract][Full Text] [Related]
15. Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma.
Van Oosterhout AJ; Van Esch B; Hofman G; Hofstra CL; Van Ark I; Nijkamp FP; Kapsenberg ML; Savelkoul HF; Weller FR
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):622-8. PubMed ID: 9761759
[TBL] [Abstract][Full Text] [Related]
16. Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB.
Goh FY; Upton N; Guan S; Cheng C; Shanmugam MK; Sethi G; Leung BP; Wong WS
Eur J Pharmacol; 2012 Mar; 679(1-3):109-16. PubMed ID: 22290391
[TBL] [Abstract][Full Text] [Related]
17. An orally active geranyl acetophenone attenuates airway remodeling in a murine model of chronic asthma.
Lee YZ; Shaari K; Cheema MS; Tham CL; Sulaiman MR; Israf DA
Eur J Pharmacol; 2017 Feb; 797():53-64. PubMed ID: 28089919
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma.
Wang Y; McCusker CT
Clin Exp Allergy; 2005 Aug; 35(8):1104-11. PubMed ID: 16120094
[TBL] [Abstract][Full Text] [Related]
19. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration.
Hessel EM; Van Oosterhout AJ; Van Ark I; Van Esch B; Hofman G; Van Loveren H; Savelkoul HF; Nijkamp FP
Am J Respir Cell Mol Biol; 1997 Mar; 16(3):325-34. PubMed ID: 9070618
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice.
Yang G; Li L; Volk A; Emmell E; Petley T; Giles-Komar J; Rafferty P; Lakshminarayanan M; Griswold DE; Bugelski PJ; Das AM
J Pharmacol Exp Ther; 2005 Apr; 313(1):8-15. PubMed ID: 15644434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
